Woman and Man
- | Country : -
- | organs : -
- | Specialty : -
Extract
?Part 1: To evaluate the safety and tolerability of ruxolitinib in combination with pemetrexed/cisplatin and select a dose for further evaluation ?Part 2: To evaluate and compare the OS of subjects with nonsquamous NSCLC that is Stage IIIB, Stage IV, or recurrent when treated with ruxolitinib or placebo in combination with pemetrexed/cisplatin and subsequently pemetrexed maintenance
Inclusion criteria
- Nonsquamous NSCLC that is Stage IIIB, Stage IV, or recurrent,CPCNP no escamoso en estadio IIIB, estadio IV o recurrente